ANDA 77329, held by Sun Pharm Inds. Octreotide Acetate.
As of Nov 16, 2026, ANDA 77329 (Octreotide Acetate), held by Sun Pharm Inds, was first approved by FDA on Mar 4, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 4, 2008 | Original application | Approved | None posted |
| Octreotide AcetateEQ 0.05MG BASE/ML · injectable;injection | Octreotide Acetate | Discontinued |
| Octreotide AcetateEQ 0.1MG BASE/ML · injectable;injection | Octreotide Acetate | Discontinued |
| Octreotide AcetateEQ 0.5MG BASE/ML · injectable;injection | Octreotide Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters